Product Images Gabapentin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Gabapentin NDC 50090-4889 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a formula for estimating creatinine clearance (ClCr) in patients, which measures how well the kidneys are filtering waste from the blood. The formula takes into account the patient's age and weight, as well as their serum creatinine level. For female patients, the result of the formula is multiplied by 0.85.*
This is a data table showing a fixed dose period of four weeks for a study on Gabapentin. Two doses of Gabapentin (1800 mg/day and 2400 mg/day) were compared to a placebo. The mean pain score was measured at baseline and throughout the trial period (1-7). No further information is available.*
This is a chart showing the proportion of responders (patients with more than 50% reduction in pain score) in controlled studies for PHN. There are two studies represented in the graph, Study 1 and Study 2, with the percentage of responders indicated for each treatment group - GBP 3600, PBO, GBP 1800, and GBP 2400. There are also some statistics indicated, with significance levels denoted in p-values, but they are not fully readable due to errors.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.